Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05624788 · ClinicalTrials.gov registry record
A Study to Characterize Access to Specialty Care Received by American Indians/Alaska Natives
A clinical trial, sponsored by Genentech.
- Completed
- Registry status
- 84
- Enrollment target
NCT05624788 is a clinical trial that has completed, run by Genentech. The registered enrollment target is 84 participants.
The verdict
NCT05624788 has completed, sponsored by Genentech.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
This is an observational study to define current care pathways for American Indian or Alaska Native patients who require specialty care and potential feasibility of conducting clinical research within the existing framework. The study is designed with the flexibility to enroll patients with any indication requiring referral to one of the following specialists: neurologist, ophthalmologist, or oncologist. Eligible patients will have recently (≤6 months) been referred to a specialty care provider and not yet seen a specialist (in addition to meeting the other eligibility criteria). The PPD virtual site can enroll patients from anywhere across the United States. The study will collect data to determine whether a patient was seen by a specialist, diagnosed with a specialized disease, patient characteristics potentially associated with being seen or not seen by a specialist, and the reasons/barriers why a patient was not seen by a specialist through a number of patient surveys.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2022-12-02 |
| Est. Completion | 2025-04-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05624788
The ClinicalTrials.gov registry entry for NCT05624788 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genentech, which has 332 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT05624788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05624788 about?
NCT05624788 is a clinical study titled "A Study to Characterize Access to Specialty Care Received by American Indians/Alaska Natives". This is an observational study to define current care pathways for American Indian or Alaska Native patients who require specialty care and potential feasibility of conducting clinical research within the existing framework. The study is designed with the flexibility to enroll patients with any indi...
What is the current status of trial NCT05624788?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2022-12-02. Estimated completion is 2025-04-15.
What interventions are being tested in trial NCT05624788?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT05624788?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.